Skip to content

PolitiKit

Lobbying by Pharmascience Inc.: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.

← Lobbying

Corporation

Pharmascience Inc.

Meetings this Parliament
175
With MPs
20
Since Nov 2021
212
Active registrations
1

Most recent reported meeting: Oct 13, 2026.

Registrations in effect

In-house (corporation) In effect since Oct 20, 2026 Receives government funding

Filed by David Goodman, Chief Executive Officer

Lobbyists

  • David Goodman · Executive Chairman
  • Julie Seïde · Director, Government Affairs
  • Ken Gagnon · Senior Manager, Government Affairs
  • Morris Goodman · Co-Founder

Institutions they may lobby: Finance Canada (FIN), Global Affairs Canada (GAC), Health Canada (HC), House of Commons, Innovation, Science and Economic Development Canada (ISED), Prime Minister's Office (PMO), Privy Council Office (PCO), Public Services and Procurement Canada (PSPC), Transport Canada (TC)

What they're lobbying on (8)
  • Policies aimed at reinforcing pharmaceutical supply chain.
  • Discussion regarding the launch of new branded product in the rare disease space
  • Improvements to the supports offered by the federal government to support R&D; in particular, generic drug research and development.
  • Seeking support from the Strategic Innovation Fund Program for support of biomanufacturing expansion project.
  • Policies aimed at facilitating generic drug repurposing.
  • Discussion on the opioid crisis and the Health minister's expectations from pharmaceutical manufacturers
  • Discussion of regulatory impediments to the launch of pediatric formulations of branded and generic products.
  • Discussion of a possible Therapeutics Products Directorate ("TPD") workstream on complex generics regulatory pathways.

Registration 725814-234102-38. Look it up in the official Registry

Reported meetings

Spreadsheet

Filed by David Goodman (205), Martin Arès (7).

  • Reported by David Goodman · In-house (corporation)

    • Majid Jowhari · Member of Parliament, House of Commons

    Health

    Official report

  • Reported by David Goodman · In-house (corporation)

    Health

    Official report

  • Reported by David Goodman · In-house (corporation)

    Health

    Official report

  • Reported by David Goodman · In-house (corporation)

    • Sandenga Yeba · Senior Policy Advisor, Health Canada (HC)

    HealthIndustry

    Official report

  • Reported by David Goodman · In-house (corporation)

    Economic DevelopmentHealthIndustry

    Official report

  • Reported by David Goodman · In-house (corporation)

    • Matthew Stenson · Policy Advisor, Global Affairs Canada (GAC)

    Government ProcurementHealth

    Official report

  • Reported by David Goodman · In-house (corporation)

    • Laurence Harvey · Senior Policy Advisor, Global Affairs Canada (GAC)
    • Camille Benoit-Blouin · Policy Advisor, Global Affairs Canada (GAC)

    HealthInternational Trade

    Official report

  • Reported by David Goodman · In-house (corporation)

    • David Hurl · Officer, Innovation, Science and Economic Development Canada (ISED)
    • Maaz Yasin · Advisor, Stakeholder Relations, Office of the Deputy Prime Minister, Prime Minister's Office (PMO)

    HealthInternational Trade

    Official report

  • Reported by David Goodman · In-house (corporation)

    Health

    Official report

  • Reported by David Goodman · In-house (corporation)

    • Shali Patel · Director of Policy, Minister’s Office, Minister of Mental Health and Addictions/Health Canada, Health Canada (HC)
    • Kaitlyn Forbes · Senior Policy Advisor, Minister’s Office, Minister of Mental Health and Addictions/Health Canada, Health Canada (HC)

    HealthIndustry

    Official report

  • Reported by David Goodman · In-house (corporation)

    • Eric Costen · Assistant Deputy Minister, Industry, Science and Economic Development Canada, Innovation, Science and Economic Development Canada (ISED)

    Economic DevelopmentHealthIndustry

    Official report

  • Reported by David Goodman · In-house (corporation)

    • Bianca Hossain · Sr Special Assistant, Innovation, Science and Economic Development Canada (ISED)

    Economic DevelopmentHealthIndustry

    Official report

From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.